Status:
COMPLETED
PROTECT: Prospective Trial on Erythropoietin in Clinical Transplantation
Lead Sponsor:
Leiden University Medical Center
Conditions:
Patients Receiving a Kidney From a Non-Heart-Beating Donor
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Randomized, double blind, placebo controlled, prospective trial investigating the effect of erythropoietin in renal transplantation. The investigators postulate that erythropoietin reduces the risk o...
Detailed Description
Randomized, double blind, placebo controlled, prospective trial in patients, receiving a kidney transplantation. Patients will be randomized to receive either Epoetin Beta (Neorecormon; Roche) or plac...
Eligibility Criteria
Inclusion
- Adult patients
- Receiving a kidney from a non-heart-beating donor category 3
Exclusion
- Donor related factors: a prolonged warm ischaemic time (\> 45 min); a cold ischaemic time of \> 24 hours; serum creatinin of \> 150 umol/l
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT00157300
Start Date
July 1 2005
End Date
July 1 2010
Last Update
August 2 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center
Leiden, Netherlands, 2300 RC
2
Other transplantation centers
To Be Determined, Netherlands